MANDY ALMOND: Open Payments
NPI 1598350746 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 17 payments from 10 companies in 2025. Trend: 2023 $51 · 2024 $567 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $127 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| Lilly USA, LLC | 2 | $32 |
| ABIOMED | 1 | $29 |
| Boston Scientific Corporation | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
Products named: Ozempic, AIRSUPRA, TRELEGY ELLIPTA, MOUNJARO, Rybelsus, WATCHMAN FLX, Wegovy, JARDIANCE.
Industry payments across TN — which companies pay providers there.
